AURA BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.89 USD | +1.54% |
|
+9.28% | -10.95% |
| 04-15 | Raj Parekh to Resign as Member of the Board of Directors of Aura Biosciences, Inc., Effective June 20, 2024 | CI |
| 03-27 | Aura Biosciences Shares Rise Following Q4 Results | MT |
Chart calendar Aura Biosciences, Inc.
200d8ddd61ca.qxvU7HolpliTD5LBGswnE5o4sGkPJAbPmmapr6UhdyA.wGmAmCpklWvqefmEc5ZVK_R071F-FjCN4zPnyJdlHlKfVYPUNBHtB9BY_Q~f2edbb7c0fd0ef91ba2b76854cbc9750
Upcoming events on Aura Biosciences, Inc.
Past events on Aura Biosciences, Inc.
| 2024-03-27 07:00 | Q4 2023 Earnings Release |
| 2024-03-12 15:40 | Leerink Partners Global Biopharma Conference |
| 2024-03-04 13:30 | TD Cowen Health Care Conference |
| 2023-11-29 16:15 | Evercore ISI HealthCONx Conference - Fireside Chat |
| 2023-11-15 09:30 | Jefferies London Healthcare Conference |
| 2023-11-09 16:05 | Q3 2023 Earnings Release |
| 2023-11-06 14:54 | American Academy Of Ophthalmology Meeting |
| 2023-08-09 07:00 | Q2 2023 Earnings Release |
| 2023-06-08 09:00 | Jefferies Global Healthcare Conference |
| 2023-06-06 | Annual General Meeting |
| 2023-05-30 10:00 | TD Cowen Oncology Innovation Summit |
| 2023-05-16 14:00 | JMP Securities Life Sciences Conference |
| 2023-05-11 16:10 | Q1 2023 Earnings Release |
| 2023-03-15 16:10 | Q4 2022 Earnings Release |
| 2023-03-08 12:50 | Cowen Health Care Conference - Panel |
| 2023-02-16 12:00 | SVB Securities Global Biopharma Conference |
| 2022-11-29 10:05 | Evercore ISI HealthCONx Conference - Fireside chat |
| 2022-11-16 10:55 | Stifel Healthcare Conference |
| 2022-11-10 07:00 | Q3 2022 Earnings Release |
| 2022-10-03 11:30 | Investor Day - Ocular Oncology |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -35,3 -33,8 -4.32% | -60,3 -59,4 -1.5% | -85,0 -81,4 -4.41% | -104 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -35,3 -33,5 -5.38% | -58,8 -57,5 -2.2% | -76,3 -73,5 -3.72% | -91,4 |
|
Net income Million USD | Released Forecast Spread | -22,2 | -46,2 -36,7 -25.75% | -58,8 -59,1 0.56% | -76,4 -73,8 -3.6% | -102 |
|
EPS USD | Released Forecast Spread | -5,99 | -1,58 -4,41 64.15% | -1,96 -1,94 -0.82% | -1,93 -1,83 -5.35% | -2,01 |
| Announcement Date | 08/10/21 | 23/03/22 | 15/03/23 | 27/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,6 -10,8 -8.16% | -12,8 -12,7 -0.87% | -13,8 -13,6 -1.59% | -16,1 -14,8 -8.85% | -17,6 -16,7 -5.36% | -19,4 -18,4 -5.53% | -20,3 -20,0 -1.44% | -20,5 -21,0 2.32% | -24,8 -21,2 -16.9% | -24,9 | -25,8 | -26,4 | -27,1 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,6 -10,3 -13.09% | -12,8 -12,7 -1.06% | -13,5 -13,5 0.04% | -15,9 -14,5 -9.98% | -16,6 -15,7 -5.21% | -17,5 -17,0 -2.74% | -18,3 -18,4 0.55% | -18,5 -19,3 4.08% | -22,0 -18,8 -16.99% | -22,4 | -23,2 | -23,5 | -23,6 | |
|
Net income Million USD | Released Forecast Spread | -12,9 -10,2 -26.64% | -12,8 -12,9 0.12% | -13,5 -13,7 1.55% | -15,9 -14,9 -6.49% | -16,6 -16,9 1.98% | -17,5 -18,3 4.47% | -18,3 -18,6 1.46% | -18,5 -19,9 6.89% | -22,1 -19,5 -13.61% | -24,1 | -25,1 | -26,1 | -27,3 | |
|
EPS USD | Released Forecast Spread | -0,67 -0,39 -70.34% | -0,44 -0,44 -1.15% | -0,46 -0,47 1.08% | -0,54 -0,51 -6.4% | -0,52 -0,52 0.48% | -0,46 -0,54 14.81% | -0,48 -0,49 2.04% | -0,48 -0,52 7.69% | -0,50 -0,41 -21.36% | -0,49 | -0,50 | -0,51 | -0,51 | -0,58 |
| Announcement Date | 23/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 15/03/23 | 11/05/23 | 09/08/23 | 09/11/23 | 27/03/24 | - | - | - | - | - |
More events
Past sector events for Aura Biosciences, Inc.
| 2024-05-02 16:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 2024-05-02 08:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-02 06:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AURA Stock
- Calendar Aura Biosciences, Inc.
